Wednesday, September 1, 2021

Clinical Data on GenSight Biologics' LUMEVOQ® and GS030 Gene Therapies to be ... - StreetInsider

“The Phase III REFLECT Trial: Efficacy and Safety of Bilateral Gene Therapy for Leber Hereditary Optic Neuropathy (LHON)” will be presented by Bart Leroy, ...

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

2 muggers captured by RU students on campus - UNB

Rayhanul Ferdous, a student of Genetic Engineering and Biotechnology department who had his phone stolen told UNB: “I was walking on the eas...